German Pilot Traces a Giant Syringe in the Sky as Vaccines Arrive

Facebook ↗WhatsApp ↗

Originally published 2020-12-29.

German Pilot Traces Outline Of Syringe In The Sky To Combat Anti-Vaccine Propaganda

Just before Europe began vaccinating against Covid-19 in December 2020, a 20-year-old German amateur pilot named Samy Kramer flew a small plane along a route that drew a giant syringe on the flight-tracking website Flightradar24. The neon-green outline stretched across southern Germany and was shared widely online as a cheerful sign that vaccines had finally arrived.

Kramer said he wanted to get people thinking about vaccination, including those who were sceptical, and to mark a hopeful moment for an aviation industry battered by the pandemic. Here is how he did it, what he actually said about his motives, and what was happening with vaccines in Europe at the time.

How the syringe was drawn

Flight-tracking services such as Flightradar24 show the path of aircraft that broadcast their position. Pilots who plan carefully can use that trail like a pen. Kramer, a student who flies as a hobby, plotted the shape in advance on a GPS device and then flew it as precisely as he could over the state of Baden-Württemberg, in the area between Lake Constance and the city of Ulm.

The flight took about an hour and 40 minutes and included several sharp 90-degree turns to form the plunger, barrel and needle. Reuters put the length of the route at about 200 kilometres; the news agency AFP reported a somewhat longer distance. Once the trace appeared on the tracking map, screenshots spread quickly across social media in the days around Christmas.

Sky drawings like this are a small online tradition. Pilots have traced hearts, animals, messages and even Christmas trees over the years, and during the pandemic several used the technique to thank health workers. Kramer's syringe stood out because it matched the news of the week so neatly.

What Kramer said about his motives

Kramer spoke to both Reuters and AFP after the flight. He told Reuters that relatively many people still opposed vaccination and that his action "may be a reminder for them to think about the topic". He added that it was partly an expression of joy for aviation, a sector that had been hit very hard by lockdowns and travel restrictions.

Some headlines presented the flight as an attack on anti-vaccine campaigners. Kramer himself was more careful. He told Reuters the flight "should not be understood as a direct call to be inoculated", and he told AFP: "I wanted to give people food for thought for the day the vaccine became available."

That nuance matters. The syringe was a symbol and a conversation starter, not medical evidence. The case for vaccination rests on clinical trials and safety monitoring, which are described below.

Europe's vaccine rollout in December 2020

The European Union coordinated the start of its campaign so that member states could begin together on 27 December 2020, a few days after the European Medicines Agency recommended the Pfizer–BioNTech vaccine. Some places, including Germany, gave the first doses a day early. Among the very first people vaccinated in Germany was a 101-year-old care home resident.

Germany expected about 1.3 million doses before the end of 2020 and between 11 and 13 million by the end of March 2021. A YouGov poll for the German news agency DPA at the time found about 65% of Germans were prepared to be vaccinated.

The United Kingdom had moved earlier. It became the first country to authorise the Pfizer–BioNTech vaccine for emergency use in early December 2020 and began vaccinating the same month, with older people and care home residents and staff first in line.

Who went first, and why

The UK, the EU and the United States all gave priority to the people most at risk: health and care workers, the very elderly, residents of care homes and people with conditions that made Covid-19 especially dangerous. Younger, healthier adults came later. The logic was simple: with limited supplies, protecting those most likely to die or need hospital care would save the most lives fastest.

How effective was the vaccine?

The Pfizer–BioNTech vaccine is an mRNA vaccine. It carries genetic instructions for a version of the coronavirus spike protein, wrapped in tiny fat particles. After the injection, cells briefly make that protein, and the immune system learns to recognise it without anyone being exposed to the virus itself.

In its phase 3 trial of more than 40,000 participants, results published in November 2020 showed 95% efficacy against symptomatic Covid-19. That figure means vaccinated volunteers had 95% fewer symptomatic cases than those given a placebo during the trial period. It does not mean the vaccine stops all infections forever; protection against infection later waned and new variants emerged, while protection against severe disease held up better, which is why booster doses were introduced.

For comparison, the seasonal flu vaccine typically reduces the risk of illness by about 40% to 60% in seasons when it matches circulating strains well, according to the US Centers for Disease Control and Prevention.

The cold-storage challenge

The Pfizer–BioNTech vaccine had to be shipped and stored at between −80 °C and −60 °C, which required special freezers. The Oxford–AstraZeneca vaccine, which uses a harmless modified virus to deliver its instructions, can be kept in an ordinary fridge. That made it much easier to distribute. The UK approved it at the end of December 2020 and began using it in early January 2021, while the EU authorised it later that month.

Vaccine confidence around the world

Kramer's comment about people opposing vaccination reflected real data. In June 2020, months before any vaccine was approved, a team led by Jeffrey Lazarus surveyed about 13,400 people in 19 countries for a study published in Nature Medicine. Around 72% overall said they would be likely to accept a proven, safe and effective Covid-19 vaccine.

Acceptance varied widely. China had the highest figure at about 89%, and Brazil was among the highest at about 85%. In the United States the figure was about 75% and in the United Kingdom 71%. France was among the lowest in Europe, at about 59%. Researchers linked higher acceptance with trust in government and in health information sources.

Why do some countries trust vaccines more than others? One frequently suggested factor is living memory. Where people remember diseases such as measles and polio killing or disabling children, the benefits of vaccination feel concrete. Where those diseases have become rare thanks to vaccines, the risks may seem abstract, and misinformation finds more room.

Why a sky drawing caught on

A light-hearted image can reach people that statistics do not. Kramer's syringe offered something simple and positive at the end of a very hard year, and it invited conversation rather than lecturing. That is also its limit: a picture cannot answer specific worries about side effects or individual health conditions.

If you have questions about any vaccine, including whether it is right for you, talk to a doctor or pharmacist. Official health agencies such as the European Medicines Agency, the UK's NHS and the CDC publish clear information about how vaccines are tested and monitored.

Sources: Reuters via The Peninsula, 27 December 2020; AFP via CBS News, 28 December 2020; Wikipedia: Pfizer–BioNTech COVID-19 vaccine; Lazarus et al., Nature Medicine (2020): A global survey of potential acceptance of a COVID-19 vaccine. Flight trace: Samy Kramer via Flightradar24.

COMMENTS